Retraction Note: Interleukin 17 acts in synergy with B cell–activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus

B Cell ◽

Lupus Erythematosus ◽

Cell Biology ◽

Interleukin 17 ◽

Systemic Lupus ◽

Faculty Opinions recommendation of Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1160897.627349 ◽

2009 ◽

Author(s):

Sarah Gaffen ◽

Allen Ho

Keyword(s):

B Cell ◽

Lupus Erythematosus ◽

Cell Biology ◽

Interleukin 17 ◽

Systemic Lupus ◽

Interleukin 17 acts in synergy with B cell–activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus

Nature Immunology ◽

10.1038/ni.1741 ◽

2009 ◽

Vol 10 (7) ◽

pp. 778-785 ◽

Cited By ~ 327

Author(s):

Agnès Doreau ◽

Alexandre Belot ◽

Jérémy Bastid ◽

Benjamin Riche ◽

Marie-Claude Trescol-Biemont ◽

...

Keyword(s):

B Cell ◽

Lupus Erythematosus ◽

Cell Biology ◽

Interleukin 17 ◽

Systemic Lupus ◽

Faculty Opinions recommendation of Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1160897.623684 ◽

2009 ◽

Author(s):

Kazuhiko Yamamoto ◽

Akiko Okamoto

Keyword(s):

B Cell ◽

Lupus Erythematosus ◽

Cell Biology ◽

Interleukin 17 ◽

Systemic Lupus ◽

Faculty Opinions recommendation of Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1160897.622324 ◽

2009 ◽

Author(s):

Laurence Morel

Keyword(s):

B Cell ◽

Lupus Erythematosus ◽

Cell Biology ◽

Interleukin 17 ◽

Systemic Lupus ◽

Faculty Opinions recommendation of Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1160897.623768 ◽

2009 ◽

Author(s):

Stefan F Martin

Keyword(s):

B Cell ◽

Lupus Erythematosus ◽

Cell Biology ◽

Interleukin 17 ◽

Systemic Lupus ◽

Interleukin-17 and B cell-activating factor in Kawasaki disease and juvenile systemic lupus erythematosus

Lupus ◽

10.1177/0961203312457211 ◽

2012 ◽

Vol 21 (11) ◽

pp. 1260-1260 ◽

Cited By ~ 2

Author(s):

SJ Park ◽

JI Shin

Keyword(s):

Kawasaki Disease ◽

B Cell ◽

Lupus Erythematosus ◽

Interleukin 17 ◽

Systemic Lupus ◽

Juvenile Systemic Lupus Erythematosus ◽

The Future of B-cell Activating Factor Antagonists in the Treatment of Systemic Lupus Erythematosus

Journal of Rheumatic Diseases ◽

10.4078/jrd.2017.24.2.65 ◽

2017 ◽

Vol 24 (2) ◽

pp. 65

Author(s):

William Stohl

Keyword(s):

B Cell ◽

Lupus Erythematosus ◽

Systemic Lupus ◽

B Cell Activating Factor ◽

The Future

AB0554 Expression of Serum B Cell Activating Factor from the Tumour Necrosis Factor Family (BAFF) and A Proliferation-Inducing Ligand (APRIL) in Systemic Lupus Erythematosus: Relationship with Disease Activity

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2014-eular.3582 ◽

2014 ◽

Vol 73 (Suppl 2) ◽

pp. 989.1-989

Author(s):

T. Panafidina ◽

M. Sokhova ◽

Z. Verizhnikova ◽

A. Novikov ◽

E. Alexandrova ◽

...

Keyword(s):

Disease Activity ◽

B Cell ◽

Tumour Necrosis Factor ◽

Lupus Erythematosus ◽

Tumour Necrosis ◽

Systemic Lupus ◽

B Cell Activating Factor ◽

Necrosis Factor

B cell activating factor (BAFF): Structure, functions, autoimmunity and clinical implications in Systemic Lupus Erythematosus (SLE)

Autoimmunity Reviews ◽

10.1016/j.autrev.2020.102736 ◽

2020 ◽

pp. 102736

Author(s):

Tamara Möckel ◽

Fabio Basta ◽

Julia Weinmann-Menke ◽

Andreas Schwarting

Keyword(s):

B Cell ◽

Lupus Erythematosus ◽

Structure Functions ◽

Clinical Implications ◽

Systemic Lupus ◽

AB0621 Expression of Serum B Cell Activating Factor from the Tumor Necrosis Factor Family (BAFF) and of Proliferation-Inducing Ligand (APRIL) in Patients with Untreated Systemic Lupus Erythematosus

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2015-eular.5107 ◽

2015 ◽

Vol 74 (Suppl 2) ◽

pp. 1107.1-1107

Author(s):

T. Panafidina ◽

M. Sokhova ◽

T. Popkova ◽

Z. Verizhnikova ◽

A. Novikov ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

B Cell ◽

Lupus Erythematosus ◽

Tumor Necrosis ◽

Systemic Lupus ◽

Tumor Necrosis Factor Family ◽

B Cell Activating Factor ◽

Necrosis Factor